FSAF1
gene geneOn this page
Also known as DKFZp547B1713
Summary
FSAF1 (40S small subunit processome assembly factor 1, HGNC:25332) is a protein-coding gene on chromosome 1q42.2, encoding 40S small subunit processome assembly factor 1 (Q8NDD1). Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. It is a selective cancer dependency (DepMap: 77.6% of cell lines).
Enables RNA binding activity. Involved in ribosomal small subunit biogenesis. Located in chromosome. Part of small-subunit processome.
Source: NCBI Gene 128061 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 19 total
- Cancer dependency (DepMap): dependent in 77.6% of screened cell lines
- MANE Select transcript:
NM_152379
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25332 |
| Approved symbol | FSAF1 |
| Name | 40S small subunit processome assembly factor 1 |
| Location | 1q42.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DKFZp547B1713 |
| Ensembl gene | ENSG00000143633 |
| Ensembl biotype | protein_coding |
| Entrez | 128061 |
Gene structure
Transcript identifiers
Ensembl transcripts: 9 — 5 protein_coding, 4 protein_coding_CDS_not_defined
ENST00000318906, ENST00000366649, ENST00000366651, ENST00000451322, ENST00000462669, ENST00000471936, ENST00000486384, ENST00000495795, ENST00000925188
RefSeq mRNA: 2 — MANE Select: NM_152379
NM_001300830, NM_152379
CCDS: CCDS1591, CCDS73049
Canonical transcript exons
ENST00000366649 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001070058 | 231238857 | 231239188 |
| ENSE00001442252 | 231225471 | 231225523 |
| ENSE00001952878 | 231241024 | 231241175 |
| ENSE00003474360 | 231229150 | 231229209 |
| ENSE00003659670 | 231226973 | 231227068 |
| ENSE00003676600 | 231226739 | 231226825 |
| ENSE00003848472 | 231223765 | 231224414 |
Expression profiles
Bgee: expression breadth ubiquitous, 241 present calls, max score 95.18.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 11.3195 / max 243.7578, expressed in 1780 samples.
FANTOM5 promoters (3 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 17976 | 10.6208 | 1769 |
| 17974 | 0.5347 | 214 |
| 17975 | 0.1641 | 78 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| ileal mucosa | UBERON:0000331 | 95.18 | gold quality |
| secondary oocyte | CL:0000655 | 93.96 | gold quality |
| tibia | UBERON:0000979 | 92.05 | gold quality |
| oocyte | CL:0000023 | 91.59 | gold quality |
| duodenum | UBERON:0002114 | 90.45 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 89.94 | gold quality |
| epithelial cell of pancreas | CL:0000083 | 89.83 | gold quality |
| jejunal mucosa | UBERON:0000399 | 89.34 | gold quality |
| rectum | UBERON:0001052 | 89.02 | gold quality |
| parietal pleura | UBERON:0002400 | 88.29 | gold quality |
| endothelial cell | CL:0000115 | 87.54 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 87.46 | gold quality |
| colonic mucosa | UBERON:0000317 | 87.39 | gold quality |
| tibialis anterior | UBERON:0001385 | 87.36 | silver quality |
| palpebral conjunctiva | UBERON:0001812 | 87.24 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 87.22 | gold quality |
| right uterine tube | UBERON:0001302 | 87.06 | gold quality |
| minor salivary gland | UBERON:0001830 | 86.98 | gold quality |
| monocyte | CL:0000576 | 86.86 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.82 | gold quality |
| leukocyte | CL:0000738 | 86.78 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.72 | gold quality |
| small intestine | UBERON:0002108 | 86.66 | gold quality |
| calcaneal tendon | UBERON:0003701 | 86.65 | gold quality |
| upper arm skin | UBERON:0004263 | 86.55 | silver quality |
| right lobe of liver | UBERON:0001114 | 86.54 | gold quality |
| granulocyte | CL:0000094 | 86.38 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 86.38 | gold quality |
| transverse colon | UBERON:0001157 | 86.31 | gold quality |
| body of pancreas | UBERON:0001150 | 86.27 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.83 |
| E-GEOD-100618 | no | 163.55 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting FSAF1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3662 | 99.99 | 73.82 | 5684 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-433-3P | 99.98 | 69.37 | 1203 |
| HSA-MIR-3692-3P | 99.98 | 70.27 | 2139 |
| HSA-MIR-520D-5P | 99.98 | 73.34 | 4883 |
| HSA-MIR-524-5P | 99.98 | 73.43 | 4882 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-MIR-493-5P | 99.96 | 72.47 | 2382 |
| HSA-MIR-3065-3P | 99.87 | 70.25 | 1407 |
| HSA-MIR-548AR-3P | 99.85 | 71.26 | 3889 |
| HSA-MIR-548BC | 99.82 | 70.61 | 3524 |
| HSA-MIR-548F-3P | 99.82 | 70.59 | 3540 |
| HSA-MIR-548AZ-3P | 99.82 | 70.56 | 3549 |
| HSA-MIR-548E-3P | 99.82 | 70.59 | 3514 |
| HSA-MIR-548A-3P | 99.76 | 70.58 | 3524 |
| HSA-MIR-4643 | 99.49 | 67.63 | 1791 |
| HSA-MIR-501-3P | 99.33 | 66.12 | 651 |
| HSA-MIR-502-3P | 99.33 | 66.12 | 651 |
| HSA-MIR-410-3P | 99.27 | 69.98 | 2457 |
| HSA-MIR-4742-3P | 98.73 | 69.82 | 1803 |
| HSA-MIR-3135B | 98.61 | 65.33 | 1470 |
| HSA-MIR-4274 | 98.59 | 66.10 | 630 |
| HSA-MIR-144-5P | 97.66 | 69.90 | 531 |
| HSA-MIR-194-3P | 97.36 | 65.96 | 1027 |
| HSA-MIR-376A-2-5P | 96.43 | 68.06 | 715 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 77.6% of screened cell lines.
Literature-anchored findings (GeneRIF, showing 1)
- The Nucleolar Protein C1orf131 Is a Novel Gene Involved in the Progression of Lung Adenocarcinoma Cells through the AKT Signalling Pathway. (PMID:38928092)
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fsaf1 | ENSDARG00000078606 |
| mus_musculus | Fsaf1 | ENSMUSG00000031984 |
| rattus_norvegicus | C19h1orf131 | ENSRNOG00000019169 |
| drosophila_melanogaster | CG1738 | FBGN0030291 |
Protein
Protein identifiers
40S small subunit processome assembly factor 1 — Q8NDD1 (reviewed: Q8NDD1)
All UniProt accessions (3): Q8NDD1, Q5TBH9, Q5TBI2
UniProt curated annotations — full annotation on UniProt →
Function. Part of the small subunit (SSU) processome, first precursor of the small eukaryotic ribosomal subunit. During the assembly of the SSU processome in the nucleolus, many ribosome biogenesis factors, an RNA chaperone and ribosomal proteins associate with the nascent pre-rRNA and work in concert to generate RNA folding, modifications, rearrangements and cleavage as well as targeted degradation of pre-ribosomal RNA by the RNA exosome. Prevents helicase DHX37 to be recruited before post-A1 state.
Subunit / interactions. Part of the small subunit (SSU) processome, composed of more than 70 proteins and the RNA chaperone small nucleolar RNA (snoRNA) U3.
Subcellular location. Chromosome. Nucleus. Nucleolus.
Isoforms (4)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NDD1-1 | 1 | yes |
| Q8NDD1-5 | 2 | |
| Q8NDD1-6 | 3 | |
| Q8NDD1-7 | 4 |
RefSeq proteins (2): NP_001287759, NP_689592* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR027973 | FSAF1-like | Family |
| IPR052852 | SSU_Processome_Comp | Family |
Pfam: PF15375
UniProt features (21 total): modified residue 6, region of interest 5, splice variant 4, compositionally biased region 3, chain 1, sequence variant 1, sequence conflict 1
Structure
Experimental structures (PDB)
2 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 7MQ8 | ELECTRON MICROSCOPY | 3.6 |
| 7MQ9 | ELECTRON MICROSCOPY | 3.87 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NDD1-F1 | 69.00 | 0.25 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (6): 78, 86, 163, 185, 279, 73
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 86 (showing top):
GOBP_RIBOSOME_BIOGENESIS, GGGNRMNNYCAT_UNKNOWN, GOBP_MATURATION_OF_SSU_RRNA, WEI_MYCN_TARGETS_WITH_E_BOX, GOBP_RIBOSOMAL_SMALL_SUBUNIT_BIOGENESIS, DODD_NASOPHARYNGEAL_CARCINOMA_UP, ZHANG_BREAST_CANCER_PROGENITORS_UP, GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS, ACEVEDO_LIVER_CANCER_UP, GOBP_RIBONUCLEOPROTEIN_COMPLEX_BIOGENESIS, IVANOVA_HEMATOPOIESIS_EARLY_PROGENITOR, NUYTTEN_EZH2_TARGETS_DN, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOCC_PRERIBOSOME, GOCC_SMALL_SUBUNIT_PROCESSOME
GO Biological Process (1): ribosomal small subunit biogenesis (GO:0042274)
GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (4): chromosome (GO:0005694), small-subunit processome (GO:0032040), nucleus (GO:0005634), nucleolus (GO:0005730)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| intracellular membraneless organelle | 2 |
| ribonucleoprotein complex biogenesis | 1 |
| ribosome biogenesis | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| nucleolus | 1 |
| preribosome | 1 |
| t-UTP complex | 1 |
| nuclear protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| nuclear lumen | 1 |
Protein interactions and networks
STRING
434 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FSAF1 | ANKRD18B | A2A2Z9 | 541 |
| FSAF1 | FAM72B | Q86X60 | 447 |
| FSAF1 | CCDC137 | Q6PK04 | 444 |
| FSAF1 | C9orf78 | Q9NZ63 | 420 |
| FSAF1 | CWC27 | Q6UX04 | 397 |
| FSAF1 | SREK1 | Q8WXA9 | 369 |
| FSAF1 | DCAF13 | Q9NV06 | 368 |
| FSAF1 | SIPA1L2 | Q9P2F8 | 366 |
| FSAF1 | ZC3H11A | O75152 | 356 |
| FSAF1 | MPHOSPH10 | O00566 | 354 |
| FSAF1 | ZNF326 | Q5BKZ1 | 353 |
| FSAF1 | PUM3 | Q15397 | 350 |
| FSAF1 | DDX27 | Q96GQ7 | 349 |
| FSAF1 | UTP4 | Q969X6 | 348 |
| FSAF1 | CLPSL2 | Q6UWE3 | 348 |
IntAct
23 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SREK1IP1 | KPNA5 | psi-mi:“MI:0914”(association) | 0.530 |
| SNN | MTDH | psi-mi:“MI:0914”(association) | 0.530 |
| MAGEB2 | GTPBP10 | psi-mi:“MI:0914”(association) | 0.530 |
| RPS3 | ZNF316 | psi-mi:“MI:0914”(association) | 0.530 |
| CDC73 | SCAMP3 | psi-mi:“MI:0914”(association) | 0.350 |
| Naa50 | WDR46 | psi-mi:“MI:0914”(association) | 0.350 |
| Ppp2ca | DKFZP586J0619 | psi-mi:“MI:0914”(association) | 0.350 |
| Gtf3c2 | PAPD5 | psi-mi:“MI:0914”(association) | 0.350 |
| KRAS | psi-mi:“MI:0914”(association) | 0.350 | |
| JUN | psi-mi:“MI:0914”(association) | 0.350 | |
| ID2 | CLASP2 | psi-mi:“MI:0914”(association) | 0.350 |
| DUSP23 | DNM1L | psi-mi:“MI:0914”(association) | 0.350 |
| INPP5K | PES1 | psi-mi:“MI:0914”(association) | 0.350 |
| LMNB1 | SUPT5H | psi-mi:“MI:0914”(association) | 0.350 |
| SNRPC | DDX39A | psi-mi:“MI:0914”(association) | 0.350 |
| EMB | RLBP1 | psi-mi:“MI:0914”(association) | 0.350 |
| NAT10 | DIS3L2 | psi-mi:“MI:0914”(association) | 0.350 |
| PRR3 | POLRMT | psi-mi:“MI:0914”(association) | 0.350 |
| CEP164 | RBFOX2 | psi-mi:“MI:2364”(proximity) | 0.270 |
| ZNF800 | MED19 | psi-mi:“MI:2364”(proximity) | 0.270 |
| NPM1 | SBNO1 | psi-mi:“MI:2364”(proximity) | 0.270 |
| FSAF1 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (66): C1orf131 (Reconstituted Complex), C1orf131 (Proximity Label-MS), C1orf131 (Proximity Label-MS), C1orf131 (Affinity Capture-MS), C1orf131 (Affinity Capture-MS), C1orf131 (Affinity Capture-MS), C1orf131 (Affinity Capture-MS), C1orf131 (Affinity Capture-MS), C1orf131 (Affinity Capture-MS), RARS (Affinity Capture-MS), EIF5B (Affinity Capture-MS), IARS (Affinity Capture-MS), KARS (Affinity Capture-MS), MYBBP1A (Affinity Capture-MS), PPP2R1A (Affinity Capture-MS)
ESM2 similar proteins: A5PJN1, O57594, O75683, P0DPK0, P53352, P70279, Q05B65, Q0VCY3, Q17QR4, Q2KIV0, Q2TBX7, Q3KRF3, Q3U155, Q3ZCI6, Q58CQ0, Q5D1Z3, Q5NVE2, Q5R939, Q5RGP9, Q5XIB5, Q5XIG5, Q5ZIH9, Q5ZMG5, Q640V3, Q641W3, Q66H19, Q6NS45, Q6PK04, Q7ZWE7, Q8BG17, Q8BK35, Q8C6C7, Q8CIL4, Q8NDD1, Q8NEF9, Q8R0K4, Q8R2N0, Q8TF30, Q96J88, Q9CR02
Diamond homologs: Q3KRF3, Q8CIL4, Q8NDD1
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
19 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 2 |
| Likely benign | 3 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1178 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:231225531:C:CT | acceptor_gain | 1.0000 |
| 1:231226734:CCTA:C | donor_loss | 1.0000 |
| 1:231226735:CTACC:C | donor_loss | 1.0000 |
| 1:231226736:TACC:T | donor_loss | 1.0000 |
| 1:231226738:C:CG | donor_loss | 1.0000 |
| 1:231226738:CCAGT:C | donor_gain | 1.0000 |
| 1:231226821:GGAGG:G | acceptor_gain | 1.0000 |
| 1:231226822:GAGG:G | acceptor_gain | 1.0000 |
| 1:231226823:AGG:A | acceptor_gain | 1.0000 |
| 1:231226824:GG:G | acceptor_gain | 1.0000 |
| 1:231226825:GCT:G | acceptor_loss | 1.0000 |
| 1:231226826:C:CC | acceptor_gain | 1.0000 |
| 1:231226826:C:CG | acceptor_loss | 1.0000 |
| 1:231226827:T:A | acceptor_loss | 1.0000 |
| 1:231226831:A:AC | acceptor_gain | 1.0000 |
| 1:231226967:CCTCA:C | donor_loss | 1.0000 |
| 1:231226968:CTCAC:C | donor_loss | 1.0000 |
| 1:231226969:TCA:T | donor_loss | 1.0000 |
| 1:231226970:CA:C | donor_loss | 1.0000 |
| 1:231226971:A:C | donor_loss | 1.0000 |
| 1:231226972:C:A | donor_loss | 1.0000 |
| 1:231226976:AGCG:A | donor_gain | 1.0000 |
| 1:231227064:CGAGC:C | acceptor_gain | 1.0000 |
| 1:231227067:GC:G | acceptor_gain | 1.0000 |
| 1:231227067:GCC:G | acceptor_loss | 1.0000 |
| 1:231227068:CC:C | acceptor_gain | 1.0000 |
| 1:231227069:C:CC | acceptor_gain | 1.0000 |
| 1:231227069:CT:C | acceptor_loss | 1.0000 |
| 1:231227070:T:C | acceptor_loss | 1.0000 |
| 1:231229148:A:AC | donor_gain | 1.0000 |
AlphaMissense
1921 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:231226995:C:G | R195P | 0.997 |
| 1:231226993:C:G | A196P | 0.996 |
| 1:231226996:G:T | R195S | 0.995 |
| 1:231226992:G:T | A196D | 0.994 |
| 1:231227053:G:C | H176D | 0.994 |
| 1:231238908:A:C | F133L | 0.994 |
| 1:231238908:A:T | F133L | 0.994 |
| 1:231238910:A:G | F133L | 0.994 |
| 1:231226978:C:G | A201P | 0.993 |
| 1:231227043:C:T | G179D | 0.993 |
| 1:231224328:A:T | L278Q | 0.992 |
| 1:231227003:T:A | E192D | 0.992 |
| 1:231227003:T:G | E192D | 0.992 |
| 1:231227049:C:G | R177P | 0.992 |
| 1:231227064:C:G | R172P | 0.992 |
| 1:231224334:A:G | L276P | 0.991 |
| 1:231226983:A:G | L199P | 0.991 |
| 1:231224348:G:C | F271L | 0.989 |
| 1:231224348:G:T | F271L | 0.989 |
| 1:231224350:A:G | F271L | 0.989 |
| 1:231226980:C:A | G200V | 0.989 |
| 1:231226983:A:T | L199Q | 0.989 |
| 1:231227068:C:G | A171P | 0.989 |
| 1:231226977:G:T | A201D | 0.988 |
| 1:231227012:T:A | R189S | 0.987 |
| 1:231227012:T:G | R189S | 0.987 |
| 1:231227046:A:G | F178S | 0.987 |
| 1:231224355:C:T | G269E | 0.986 |
| 1:231226980:C:T | G200D | 0.985 |
| 1:231226981:C:G | G200R | 0.985 |
dbSNP variants (sampled 300 via entrez): RS1000162775 (1:231240337 A>C), RS1000216146 (1:231228060 C>T), RS1000298223 (1:231233317 C>T), RS1000452504 (1:231226601 C>G,T), RS1000586116 (1:231227194 C>A,G), RS1000619601 (1:231239895 C>T), RS1000902862 (1:231228386 G>C), RS1000960746 (1:231240326 G>A), RS1001048492 (1:231232837 T>C), RS1001297786 (1:231238690 A>G), RS1001498192 (1:231231657 G>A), RS1001514239 (1:231233622 G>A,C), RS1002224292 (1:231225625 T>C), RS1002255519 (1:231225851 G>A), RS1002594048 (1:231224658 T>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, increases abundance, increases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| FR900359 | decreases phosphorylation | 1 |
| dicrotophos | decreases expression | 1 |
| kojic acid | decreases expression | 1 |
| trichostatin A | affects expression | 1 |
| beta-lapachone | increases expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| manganese chloride | increases expression, increases abundance | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| erucylphospho-N,N,N-trimethylpropylammonium | decreases expression | 1 |
| Temozolomide | increases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Arsenic | increases abundance, increases expression | 1 |
| Azathioprine | decreases expression | 1 |
| Coal | increases abundance, increases expression | 1 |
| Dimethyl Sulfoxide | increases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Hydrogen Peroxide | affects expression | 1 |
| Manganese | increases expression, increases abundance | 1 |
| Ribonucleotides | affects binding | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Thiram | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Valproic Acid | affects expression | 1 |
| Zinc | decreases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Sodium Selenite | increases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_B1LS | Abcam HeLa C1orf131 KO | Cancer cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.